Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
UT Health San Antonio Innovates Breakthrough in Drug Discovery
Researchers at UT Health have achieved a significant breakthrough through a novel concept known as "chemical endocytic medicinal chemistry," which aims to transform how drugs are designed for cellular uptake....
uniQure’s AMT-130 Receives FDA Breakthrough Designation for Huntington’s Treatment
uniQure’s investigational gene therapy, AMT-130, has received Breakthrough Therapy designation from the U.S. FDA for the treatment of Huntington’s disease, a rare and inherited neurodegenerative disorder with no approved therapies that alter its progression....
Oregon State University Researchers Discover Novel Drug Delivery Platform for Alzheimer’s and Brain Disorders
Researchers at Oregon State University have developed a method to deliver anti-inflammatory medicines across the blood-brain barrier, offering new possibilities for treating a range of conditions...
Stanford Researchers Develop Breakthrough Liquid Biopsy for Cancer Resistance and Tissue Injury
Researchers at Stanford Medicine have developed a new blood test that can detect cancers, identify treatment resistance, and monitor tissue damage caused by non-cancerous conditions. The test works by analysing fragments of RNA found circulating in the bloodstream, known as cell-free RNA (cfRNA)....
Alpha Cognition Launches Breakthrough ZUNVEYL for Mild to Moderate Alzheimer’s
Alpha Cognition, a biopharmaceutical company focused on neurodegenerative diseases, has officially launched ZUNVEYL, a new treatment for individuals with mild to moderate Alzheimer’s disease. ...
Imfinzi Approved in EU as First Immunotherapy for Limited-Stage SCLC
AstraZeneca's Imfinzi (durvalumab) has received approval in the European Union (EU) for use as a monotherapy in adults with limited-stage small cell lung cancer (LS-SCLC). The treatment is specifically for patients whose...
Olverembatinib Receives Breakthrough Therapy Designation for Treating Philadelphia Chromosome-Positive (Ph+) ALL
Olverembatinib has been granted Breakthrough Therapy Designation (BTD) by China’s National Medical Products Administration (NMPA) through the Centre for Drug Evaluation (CDE). ...
The University of Texas MD Anderson Cancer Center Develops Novel Antibody-Toxin Conjugate
Researchers at The University of Texas MD Anderson Cancer Center have developed an innovative antibody-toxin conjugate (ATC) designed to stimulate the immune system to eliminate tumours. This new approach combines the advantages of both antibody-drug conjugates...
FDA Grants Breakthrough Therapy Designation for Petosemtamab in 1L PD-L1+ Head and Neck Cancer
Merus N.V has announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation for petosemtamab in combination with pembrolizumab. This designation applies to the first-line treatment of adult patients with recurrent or metastatic programmed...
Inhalon Biopharma Introduces First-of-its-Kind Inhaled Antibody Therapy for RSV Advancing to Human Trials
Inhalon Biopharma focused on inhaled antibody therapies for acute respiratory infections (ARI), has completed studies required to support an investigational new drug (IND) application for its respiratory syncytial virus (RSV) candidate, IN-002. ...
